Passive Immunization: The Expanding Role of Monoclonal Antibodies in Preventive Medicine
For governments and health systems, monoclonal antibodies represent not just another drug class, but a strategic shift toward precision prevention.
A Covid-19 reflection: Incorporating what we’ve learned for improved preparedness
Beyond preparedness policies, we need to think forward to policies that rapidly identify the spread of zoonotic disease to prevent or minimize the impact.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Easing the bottleneck challenges for coronavirus testing
Pandemic preparedness funding needs to be focused on developing technologies that can be quickly adapted to any new pathogen, and scaled rapidly, ensuring stockpile and manufacturing capacity for key items such as swabs and sample transport media, and laboratory preparedness to shift rapidly to focused testing.